NCT00005999View on ClinicalTrials.gov

Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2000

Study Completion Date

May 31, 2003

Conditions
Cervical Cancer
Interventions
DRUG

arsenic trioxide

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00005999 - Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer | Biotech Hunter | Biotech Hunter